Starling Oncology, Inc. (DFPH)

2.01USD +0.50% (+0.01)

Over 6M: -79.8%

2025-12-11
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

5 10
Jun Aug Oct Mar Oct Dec

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 52.3M Q4 '21 — Revenue: 52.3M Q1 '22 — Revenue: 55.2M Q2 '22 — Revenue: 60.9M Q3 '22 — Revenue: 65M Q4 '22 — Revenue: 71.4M Q1 '23 — Revenue: 76.2M Q2 '23 — Revenue: 80.2M Q3 '23 — Revenue: 82M Q4 '23 — Revenue: 85.8M Q1 '24 — Revenue: 94.7M Q2 '24 — Revenue: 98.6M Q3 '24 — Revenue: 99.9M Q4 '24 — Revenue: 100.3M Q1 '25 — Revenue: 104.4M Q2 '25 — Revenue: 119.8M Q3 '25 — Revenue: 136.6M Q4 '25 — Revenue: 142M Q1 '26 — Revenue: 147.4M Q2 '26 — Revenue: 161.3M 0 35M 70M 105M 140M 175M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 62 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.4
SBC / sales 0.87%
OE margin -1.4%
Oper. margin -4.4%
ROIC -148.2%
Accruals -20.5%
FCF margin -0.56%
OCF margin 0.056%
ROA -20.4%
ROCE -31.3%
Gross margin —
OCF / EBIT —
ROE —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

5.7
EV/Sales 0.41×
EV/OE -29.1×
P/C 5.0×
FCF yield -1.6%
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/B —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.3
RPO / sales 0.0039×
Segment HHI 0.49 HHI
RPO growth —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.8
ND/EBITDA -0.16
Cash / Debt 0.51×
Quick ratio 1.1×
F-score 4.5 pts
Cash runway —
Debt / Eq —
Debt payback —
Equity / Assets —
Net debt / Eq —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

6.2
Sales CAGR 4Y +25.4%
Sales/sh Y/Y +12.4%
Sales Q/Q +34.6%
Shares change +23.1%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.